Nucleic Acids Research, 1990, Vol. 18, No. 4 763-769
© 1990
MOLECULAR BIOLOGY |
Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites
Institute of Molecular and Cell Biology, National University of Singapore Kent Ridge, 0511 Singapore
*To whom correspondeoce should be addressed
+Present address: Techmcal University of Darmstadt, Institute of Biochemistry, Petersenstraße 22, 6100 Darms PRO
Received November 21, 1989. Revised January 26, 1990. Accepted January 26, 1990.
The promoter P97 of human papillomavirus-16 (HPV-16) gives rise to transcripts that encode the principal transforming genes of the virus, E6 and E7. The activity of P97 is regulated by a cell-type-specific enhancer, as well as by glucocorticolds and progesterone. We show here, that in CaSki cells, which contain HPV-16 genomes, P97 is also inducible by phorbol esters. Functional analysis of restriction fragments and oligonucleotides of the viral enhancer localizes two phorbol eater response elements on two transcription factor binding sites termed fp4e and fp9e. Sequence comparison, footprint analysis and bandshift competition of the cloned motifs suggest that both fp4e and fp9e are bound by the transcription factor AP1. These AP1 binding sites in HPV-16 and other papillomaviruses may provide a link between cellular oncogenes like jun, fos and possibly ras, whose transcription stimulating activity may lead to an elevated expression of the viral transforming genes E6 and E7.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Z. Chen, M. Schiffman, R. Herrero, and R. D. Burk Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106 J. Gen. Virol., November 1, 2007; 88(11): 2952 - 2955. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Campo-Fernandez, D. Morandell, F. R. Santer, W. Zwerschke, and P. Jansen-Durr Identification of the FHL2 Transcriptional Coactivator as a New Functional Target of the E7 Oncoprotein of Human Papillomavirus Type 16 J. Virol., January 15, 2007; 81(2): 1027 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Carson and S. A. Khan Characterization of Transcription Factor Binding to Human Papillomavirus Type 16 DNA during Cellular Differentiation J. Virol., May 1, 2006; 80(9): 4356 - 4362. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Behren, C. Simon, R. M. Schwab, E. Loetzsch, S. Brodbeck, E. Huber, F. Stubenrauch, H. P. Zenner, and T. Iftner Papillomavirus E2 Protein Induces Expression of the Matrix Metalloproteinase-9 via the Extracellular Signal-Regulated Kinase/Activator Protein-1 Signaling Pathway Cancer Res., December 15, 2005; 65(24): 11613 - 11621. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Hubert Variant Upstream Regulatory Region Sequences Differentially Regulate Human Papillomavirus Type 16 DNA Replication throughout the Viral Life Cycle J. Virol., May 15, 2005; 79(10): 5914 - 5922. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Spink and L. A. Laimins Induction of the Human Papillomavirus Type 31 Late Promoter Requires Differentiation but Not DNA Amplification J. Virol., April 15, 2005; 79(8): 4918 - 4926. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baldwin, L. Pirisi, and K. E. Creek NFI-Ski Interactions Mediate Transforming Growth Factor {beta} Modulation of Human Papillomavirus Type 16 Early Gene Expression J. Virol., April 15, 2004; 78(8): 3953 - 3964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terai and R. D. Burk Felis domesticus papillomavirus, isolated from a skin lesion, is related to canine oral papillomavirus and contains a 1{middle dot}3 kb non-coding region between the E2 and L2 open reading frames J. Gen. Virol., September 1, 2002; 83(9): 2303 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terai and R. D. Burk Characterization of a novel genital human papillomavirus by overlapping PCR: candHPV86 identified in cervicovaginal cells of a woman with cervical neoplasia J. Gen. Virol., September 1, 2001; 82(9): 2035 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Tornesello, F. M. Buonaguro, L. Buonaguro, I. Salatiello, E. Beth-Giraldo, and G. Giraldo Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas J. Gen. Virol., December 1, 2000; 81(12): 2969 - 2982. [Abstract] [Full Text] |
||||
![]() |
C. Kämmer, U. Warthorst, N. Torrez-Martinez, C. M. Wheeler, and H. Pfister Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity J. Gen. Virol., August 1, 2000; 81(8): 1975 - 1981. [Abstract] [Full Text] |
||||
![]() |
D. Ndisang, V. Budhram-Mahadeo, and D. S. Latchman The Brn-3a Transcription Factor Plays a Critical Role in Regulating Human Papilloma Virus Gene Expression and Determining the Growth Characteristics of Cervical Cancer Cells J. Biol. Chem., October 1, 1999; 274(40): 28521 - 28527. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lewis, K. Webster, A.-M. Sanchez-Perez, and K. Gaston Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein J. Gen. Virol., August 1, 1999; 80(8): 2087 - 2096. [Abstract] [Full Text] |
||||
![]() |
X.-P. Dong and H. Pfister Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16 J. Gen. Virol., August 1, 1999; 80(8): 2097 - 2101. [Abstract] [Full Text] |
||||
![]() |
M. J. O'Connor, W. Stunkel, H. Zimmermann, C.-H. Koh, and H.-U. Bernard A Novel YY1-Independent Silencer Represses the Activity of the Human Papillomavirus Type 16 Enhancer J. Virol., December 1, 1998; 72(12): 10083 - 10092. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. La Celle and R. R. Polakowska Human Homeobox HOXA7 Regulates Keratinocyte Transglutaminase Type 1 and Inhibits Differentiation J. Biol. Chem., August 24, 2001; 276(35): 32844 - 32853. [Abstract] [Full Text] [PDF] |
||||



